CLINICAL-MORPHOLOGICAL AND FUNCTIONAL CHANGES OF RENAL SYSTEM IN HIV-INFECTED
DOI:
https://doi.org/10.11603/1681-2727.2016.2.6526Keywords:
HIV infection, HIV-associated nephropathy, focal segmental glomerulosclerosis, chronic renal failure, glomerular filtration rate, protein tsystatyn.Abstract
It is established that the virus HIV affects the renal system. The data that antiretroviral therapy (HAART) has negative effects on the kidneys and their function. Also found that are morphological and functional changes in the nature of the HIV-infected. In the literature describes few data on drug correction of these changes.
References
Kuchmenko O.B. Problemy SNIDu v Ukraini ta metodyka podolannia / O.B. Kuchmenko // Problemy osvity. – 2006. – № 48. – S. 27-31.
VIL-infektsiia v Ukraini: Inf. biuleten № 41. − K.: MOZ Ukrainy, Inf. Tsentr profilaktyky i borotby zi SNIDom, 2014. – 24 s.
VIL-infektsiia v Ukraini: Inf. biuleten № 44. − K.: MOZ Ukrainy, Inf. Tsentr profilaktyky i borotby zi SNIDom, 2015. – 24 s.
Stan imunnoi systemy u khvorykh na VIL-infektsiiu/SNID pid vplyvom antyretrovirusnoi terapii / [V.D. Moskaliuk, V.D. Sorokhan, S.R. Melenko ta in.] // Naukowa przestrzeń Europy. – 2013. – № 29. – S. 87-88.
Rojt A. Immunologiya / A. Rojt, Dzh. Brostoff, D. Mejl: Per. s angl. – M.: Mir, 2000. – 592 s.
Chornetska V.D. Deiaki medyko-biolohichni aspekty formuvannia u studentiv uiavlennia pro nebezpeku VIL/SNID / V.D. Chornetska // Problemy osvity. – 2006. – № 48. – S. 32-37.
Zaplatynskyi V.M. Pytannia profilaktyky VIL/SNIDu u haluzevykh standartakh vyshchoi osvity / V.M. Zaplatynskyi, V.D. Chornenka // BZhD: osvita, nauka, praktyka: Materialy VI nauk.-metod. konf. – K.: NAU, 2005. – S. 87-92.
Kocharyan K.A. Kliniko-laboratornaya kharakteristika porazhenij pochek u VICh-inficirovanny'kh pacientov: avtoref. dis. … kand. med. nauk / K.A. Kocharyan. – M., 2012. – 20 s.
Varianty' porazheniya pochek pri VICh-infekcii / [N.D. Yushhuk, G.V. Volgina, Yu.V. Marty'nov i dr.] // Terapevt. arkhiv. – 2008. – № 12. – S. 78-81.
Predictors of renal outcome in HIV-associated nephropathy / [F.A. Post, L.J. Campbell, L. Hamzah et al.] // Clin. Infect. Dis. − 2008. − Vol. 46. − P. 1282-1289.
Pervy'j opy't primeneniya tenofovira pri lechenii bol'ny'kh VICh-infekciej v Rossii / [O.G. Yurin, M.D. Goliusova, M.O. Deulina i dr.] // E'pidemiologiya i infekcionny'e bolezni. – 2013. – №1. – S. 62-69.
Kimmel P.L. The nephropathies of HIV infection: pathogenesis and treatment / P.L. Kimmel // Curr. Opin. Nephrol. Hypertens. − 2000. − Vol. 9. − P. 117-122.
Riabokon O.V. Osoblyvosti urazhennia nyrok v umovakh vysokoaktyvnoi antyretrovirusnoi terapii u khvorykh na VIL/SNID / O.V. Riabokon, T.Ie. Onyshchenko, O.L. Koltunik // Patolohiia. – 2013. – № 2 (28). – S. 85-87.
Kimmel P.L. Immune complex glomerulonephritis associated with HIV infection / P.L. Kimmel, J.S. Berns, J.H. Stein. − New York: Churchill Livingstone, 1995. – R. 77-110.
Scialla J.J. Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy / J.J. Scialla, M.G. Atta, D.M. Fine // AIDS. – 2007. – Vol. 21, N 2. – P. 263-264.
Gorobec O.P. Osobennosti VICh-associirovannoj nefropatii v zavisimosti ot stepeni immunnoj nedostatochnosti / O.P. Gorobec, V.S. Gozhenko, A.I. Gojdy'k // Bukovins'kij medichnij vіsnik – 2012. – T. 16, № 3 (63), ch. 2. – S. 91-92.
Mochevoj sindrom u VICh-inficirovanny'kh bol'ny'kh v stadii SPIDa / [A.I. Gozhenko, O.P. Gorobec, V.S. Gojdy'k i dr.] // Nefrologiya. – 2008. – № 12 (4). – S. 54-58.
Hozhenko A.I. Piielonefryt u VIL-infikovanykh khvorykh u stadii SNIDu / A.I. Hozhenko, O.P. Horobets, V.S. Hoidyk // Dermatovenerolohyia. Kosmetolohyia. Seksopatolohyia. – 2008. – № 1-2. – S. 233-236.
Bartlett D. Klinicheskie aspekty' VICh-infekcii / D. Bartlett, D. Gallant, P. Fam. – M.: R. Valent, 2012. – 528 s.
Fanconi syndrome and renal failure induced by tenofovir: a first case report / [D. Verhelst, M. Monge, J.L. Meynard et al.] // Am. J. Kidney Dis. – 2002. – Vol. 40. − P. 1331-1333.
Gadzhikulieva M.M. Khronicheskaya bolezn' pochek u VICh-inficirovanny'kh pacientov, rasprostranennost' i kliniko-morfologicheskaya kharakteristika: avtoref. dis. … dokt. med. nauk / M.M. Gadzhikulieva.– M., 2013. – 47 s.
Andrew M. Tenofovir-associated kidney toxicity in HIV-Infected patients / M. Andrew // Am. J. Kidney Dis. – 2011. – N 57. – P. 773-780.
Paul L. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations / L. Paul // Ibid. – 2003. – N 139. – S 87-100.
Sacristian F. Nephrotic syndrome due to thrombotic microangiopathy (TMA) as the first manifestation of human immunodeficiency virus infection: recovery before antiretroviral therapy without specific treatment against TMA / F. Sacristian, S. Alonso // Clin. Nephrol. – 2001. − Vol. 55. − P. 404-407.
Bondarenko V.N. Ocenka funkcii pochek u VICh-inficirovanny'kh pacientov: kreatinin ili cistatin S? (obzor literatury') / V.N. Bondarenko // Problemy' zdorov'ya i e'kologii – 2012. – № 1. – S. 15-19.
Jones C.Y. Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study / C.Y. Jones // Am. J. Kidney Dis. – 2008. – Vol. 51. – P. 914-924.
Overton E.T. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy / E.T. Overton // HIV Med. – 2009. – Vol. 10. – P. 343-350.
Esezobor C.I. Kidney function of HIV-infected children in Lagos, Nigeria: using Fillers serum cystatin C-based formula / C.I. Esezobor // J. Int. AIDS Soc. – 2010. – Vol. 13. – P. 17.
Jaroszewicz J. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration / J. Jaroszewicz // Antivir. Ther. – 2006. – Vol. 11. – P. 641-645.
Briggs W.A. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy / W.A. Briggs, S. Tanawattanacharoen, M.J. Choi // Am. J. Kidney Dis. – 1996. − Vol. 28. − P. 618-621.
Chidambaram M. Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection / M. Chidambaram, C.E. Stigant, L.M. Sugar // Clin. Nephrol. – 2002. − Vol. 57. − P. 154-157.
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
